Therapeutics: Factor XIIa; β-amyloid 42 (Aβ42)

Studies in patient samples and mice suggest systemic Factor XIIa inhibition could help treat AD. In serum from AD patients, levels of Factor XIIa and markers of kallikrein - which cleaves high molecul...